Navigation Links
Novel DNA vaccine leads to kidney damage prevention in systemic lupus erythematosus models
Date:6/11/2009

Copenhagen, Denmark, Thursday 11 June 2009: DNA vaccination using lupus autoantigens and interleukin-10 (IL-10, a cytokine that plays an important role in regulating the immune system) has potential as a novel therapy to induce antigen specific tolerance and may help to prevent kidney damage in patients with systemic lupus erythematosus (SLE), according to a new study presented today at EULAR 2009, the Annual Congress of the European League Against Rheumatism in Copenhagen, Denmark.

SLE is a complex, chronic autoimmune disease that causes inflammation and damage to body tissues. Inflammation of the kidney can cause kidney failure, often a significant complication of SLE associated with the more severe forms of the disease, and the primary cause of disability that leads to other fatal complications in people with the condition.

In the study, one group of experimental mice was vaccinated with Sm (Smith antigens that are small nuclear ribonucleoproteins: snRNPs) lupus autoantigen in combination with IL-10 and another group vaccinated with the same antigen and IFN-gamma, both signaling molecules involved in the immune process. SLE was induced in the mice and the levels of antibodies against various lupus autoantibodies were analysed. The study found that levels of anti-Sm antibodies in the IL-10 vaccinated group were lower than those in the group vaccinated with IFN-gamma (p=0.026, statistically significant).

Interestingly, the prevalence and levels of other autoantibodies such as anti-Argonaute2 (Ago2)/Su and chromatin did not differ between the groups, indicating that the vaccination was Sm antigen-specific and successfully targeting particular antibodies. Significant proteinuria (a urinary condition which can indicate kidney damage) (>1.5+) was less common in the IL-10 vaccinated group compared with the IFN-gamma group, which may suggest a beneficial role for IL-10 vaccination in preventing kidney damage associated with SLE.

Dr Monica Vazquez del Mercado, Head of the Instituto de Investigacin en Reumatologa y del Sistema Msculo Esqueltico of the Universidad de Guadalajara, Mexico, corresponding author of the study, said: "Some autoantibodies are specific for SLE and are considered to be characteristic of the condition. The mechanisms that regulate the production of these antibodies are poorly understood, however, the results of our study have identified one possible way of influencing the pathway behind kidney damage in SLE."

Studies in human and mouse models of lupus have revealed that the major epitopes of the anti-Sm antibodies are present at specific locations (D1, D2 and B/B) of the Sm antigens. Researchers in this study prepared DNA vaccines of Sm D1, D2, B/B, B/BCOOH, IFN-gamma and IL-10 using direct cloning techniques with pcDNA"3.1D/V5-His-TOPO and purified these using Qiagen Endo-Free Giga Prep Kit. Eight groups of 6 week-old female BALB/c mice (13/group) received intramuscular injections of 100 micrograms of the vaccination preparation at days 2 and 9. At day 16, mice were induced with experimental SLE.

Serum samples were collected at day 0 and then monthly for analysis of autoantibodies and immunoglobulin levels. Serum autoantibodies were tested by immunoprecipitation and ELISA. Proteinuria (excessive protein in the urine) was assessed monthly using Multistix. Kidney pathology and immune complex deposition were examined at 6 months.


'/>"/>

Contact: Rory Berrie
eularpressoffice@uk.cohnwolfe.com
44-078-643-86425
European League Against Rheumatism
Source:Eurekalert

Related medicine news :

1. Animal model for schizophrenia identifies a novel approach for treating cognitive impairments
2. Health Department Reports Pennsylvanias First Death Due to 2009 Novel Influenza A/H1N1 Virus
3. Ortho Biotech Oncology Research & Development Announces Collaboration with National Cancer Institute to Develop Novel Cell Therapies to Treat Cancer
4. Pitt melanoma researchers present novel findings at ASCO
5. Novel biomarkers in heart failure
6. Kyowa Hakko USA Announces GRAS Self-Affirmation for Novel Brain Health Ingredient Cognizin(R) Citicoline
7. Stand Up to Cancer awards $73.6 million for novel, groundbreaking cancer research
8. A novel marker of colorectal carcinoma
9. Novel approach estimates nanoparticles in environment
10. The Launch and Uptake of More Than 20 Novel Drugs Over The Next 10 Years Will Drive $12.5 Billion Growth in the Type 2 Diabetes Market
11. Results of phase III study on Labopharms novel antidepressant published in Psychiatry (Edgemont) Journal
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... ... January 23, 2017 , ... "ProRandom is a set of camera tools that allow video ... in Final Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. ... of text with video footage. ProRandom works by using a virtual camera to create ...
(Date:1/23/2017)... ... January 23, 2017 , ... ... Society of Anesthesiologists® (ASA®), the Foundation for Anesthesia Education and Research (FAER), ... (AAOS) and the Cigna Foundation, encourages proposals supporting high quality research using ...
(Date:1/23/2017)... ... ... a story of love and redemption, hope and uncertainty as a girl makes her way ... at the Mill” is the creation of published author, Lois Kulp, who was born in ... County on Crow Hill. The inn, the mill and "Post Yokel" are within ...
(Date:1/23/2017)... , ... January 23, 2017 ... ... (SNP) has launched online education programs and resources at seafoodnutrition.org/programs and seafoodnutrition.org/resources ... benefits of a seafood-rich diet. These resources have been developed for use ...
(Date:1/23/2017)... ... ... “Some Infallible Characteristics of Christ”: a fascinating and entrancing novel exploring the gifts ... published author, Rev. Dr. Robert W. Thomas, the third of seven siblings. He was ... a pastor for over fifteen years. He is a graduate of N.C. College of ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... janvier 2017  ResMed (NYSE : RMD), BMC (Pékin, Chine) ... annoncé aujourd,hui qu,ils se sont mis d,accord sur le ... parties. BMC et 3B seront autorisés à vendre leurs ... ResMed, et ResMed effectuera le paiement de la décision ... litige de Floride entre les deux parties. Le règlement ...
(Date:1/23/2017)... 2017 NeuroVive Pharmaceutical AB (Nasdaq Stockholm: ... preclinical collaboration agreement with the Children,s Hospital of ... M.D., a US key opinion leader in the mitochondrial medicine ... ... from NeuroVive,s research program, NVP015, in certain experimental disease models. ...
(Date:1/22/2017)... DAVOS, Switzerland and ABU DHABI , ... leaders from the US ... , Hospital of the Future , at ... in the hospital of the future will be driven by big data and ... better," according to the panel of experts that discussed the ,Hospital of the ...
Breaking Medicine Technology: